Laboratorio Elea started operating on December 30, 1939. It stands out for high complexity products like Enper, an antiviral for AIDS treatment; Va-Mengoc-BC, a vaccine for meningitis treatment and in the biotechnology area, IOR-T3, a monoclonal antibody for the prevention and treatment for acute rejection of organ transplant and Biovac HB for hepatitis treatment.
Headquarters
Sanabria 2353
Buenos Aires (City); Federal Capital;
Postal Code: C1417AZE
Contact Details: Purchase the Laboratorio Elea S.A.C.I.F.I.A. report to view the information.
Website: http://www.elea.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service